The Impact of Glucagon-Like Peptide-1 Agonists on Hip and Knee Arthroplasty and Perioperative Considerations

Jacofsky, D. J., Springer, B. D., Mont, M. A., Ushakumari, D. S., & Sladen, R. N. (2024). The Impact of Glucagon-Like Peptide-1 Agonists on Hip and Knee Arthroplasty and Perioperative Considerations. The Journal of Arthroplasty, 39(6), 1455–1458. https://doi.org/10.1016/j.arth.2023.12.002
Authors:
David J Jacofsky
Bryan D Springer
Michael A Mont
Deepu S Ushakumari
Robert N Sladen
Affiliated Authors:
Robert N Sladen
Columbia Affiliation:
Subjects:
Arthroplasty, Replacement, Knee (MeSH)
Arthroplasty, Replacement, Hip (MeSH)
Glucagon-Like Peptide 1 (MeSH)
Hypoglycemic Agents (MeSH)
Author Keywords:
glucagon-like peptide-1 agonists
total hip and knee
perioperative management
diabetes
obesity
elink
Publication Type:
Article
Unique ID:
10.1016/j.arth.2023.12.002
PMID:
38070716
DOI:
10.1016/j.arth.2023.12.002
Journal:
Journal of Arthroplasty
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: